Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development

Cheryl A Conover, Laurie K. Bale, Michael T. Overgaard, Edward W. Johnstone, Ulla L. Laursen, Ernst Martin Füchtbauer, Claus Oxvig, Jan Van Deursen

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

Pregnancy-associated plasma protein A (PAPPA) is a metzincin superfamily metalloproteinase in the insulin-like growth factor (IGF) system. PAPPA increases IGF bioavailability and mitogenic effectiveness in vitro through regulated cleavage of IGF-binding protein 4 (IGFBP4). To determine its function in vivo, we generated PAPPA-null mice by gene targeting. Mice homozygous for targeted disruption of the PAPPA gene were viable but 60% the size of wild-type littermates at birth. The impact of the mutation was exerted during the early embryonic period prior to organogenesis, resulting in proportional dwarfism. PAPPA, IGF2 and IGFBP4 transcripts co-localized in wild-type embryos, and expression of IGF2 and IGFBP4 mRNA was not altered in PAPPA-deficient embryos. However, IGFBP4 proteolytic activity was completely lacking in fibroblasts derived from PAPPA-deficient embryos, and IGFBP4 effectively inhibited IGF-stimulated mitogenesis in these cells. These results provide the first direct evidence that PAPPA is an essential growth regulatory factor in vivo, and suggest a novel mechanism for regulated IGF bioavailability during early fetal development.

Original languageEnglish (US)
Pages (from-to)1187-1194
Number of pages8
JournalDevelopment
Volume131
Issue number5
DOIs
StatePublished - Mar 2004

Fingerprint

Pregnancy-Associated Plasma Protein-A
Metalloproteases
Fetal Development
Insulin-Like Growth Factor Binding Protein 4
Intercellular Signaling Peptides and Proteins
Somatomedins
Embryonic Structures
Biological Availability
Dwarfism
Gene Targeting
Organogenesis
Fibroblasts
Parturition
Messenger RNA
Mutation

Keywords

  • Gene targeting
  • Insulin-like growth factor
  • Metalloproteinase
  • Pregnancy associated plasma protein A

ASJC Scopus subject areas

  • Cell Biology
  • Anatomy

Cite this

Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. / Conover, Cheryl A; Bale, Laurie K.; Overgaard, Michael T.; Johnstone, Edward W.; Laursen, Ulla L.; Füchtbauer, Ernst Martin; Oxvig, Claus; Van Deursen, Jan.

In: Development, Vol. 131, No. 5, 03.2004, p. 1187-1194.

Research output: Contribution to journalArticle

Conover, Cheryl A ; Bale, Laurie K. ; Overgaard, Michael T. ; Johnstone, Edward W. ; Laursen, Ulla L. ; Füchtbauer, Ernst Martin ; Oxvig, Claus ; Van Deursen, Jan. / Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. In: Development. 2004 ; Vol. 131, No. 5. pp. 1187-1194.
@article{a37beea50f5945a7a01519f71c881028,
title = "Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development",
abstract = "Pregnancy-associated plasma protein A (PAPPA) is a metzincin superfamily metalloproteinase in the insulin-like growth factor (IGF) system. PAPPA increases IGF bioavailability and mitogenic effectiveness in vitro through regulated cleavage of IGF-binding protein 4 (IGFBP4). To determine its function in vivo, we generated PAPPA-null mice by gene targeting. Mice homozygous for targeted disruption of the PAPPA gene were viable but 60{\%} the size of wild-type littermates at birth. The impact of the mutation was exerted during the early embryonic period prior to organogenesis, resulting in proportional dwarfism. PAPPA, IGF2 and IGFBP4 transcripts co-localized in wild-type embryos, and expression of IGF2 and IGFBP4 mRNA was not altered in PAPPA-deficient embryos. However, IGFBP4 proteolytic activity was completely lacking in fibroblasts derived from PAPPA-deficient embryos, and IGFBP4 effectively inhibited IGF-stimulated mitogenesis in these cells. These results provide the first direct evidence that PAPPA is an essential growth regulatory factor in vivo, and suggest a novel mechanism for regulated IGF bioavailability during early fetal development.",
keywords = "Gene targeting, Insulin-like growth factor, Metalloproteinase, Pregnancy associated plasma protein A",
author = "Conover, {Cheryl A} and Bale, {Laurie K.} and Overgaard, {Michael T.} and Johnstone, {Edward W.} and Laursen, {Ulla L.} and F{\"u}chtbauer, {Ernst Martin} and Claus Oxvig and {Van Deursen}, Jan",
year = "2004",
month = "3",
doi = "10.1242/dev.00997",
language = "English (US)",
volume = "131",
pages = "1187--1194",
journal = "Development (Cambridge)",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "5",

}

TY - JOUR

T1 - Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development

AU - Conover, Cheryl A

AU - Bale, Laurie K.

AU - Overgaard, Michael T.

AU - Johnstone, Edward W.

AU - Laursen, Ulla L.

AU - Füchtbauer, Ernst Martin

AU - Oxvig, Claus

AU - Van Deursen, Jan

PY - 2004/3

Y1 - 2004/3

N2 - Pregnancy-associated plasma protein A (PAPPA) is a metzincin superfamily metalloproteinase in the insulin-like growth factor (IGF) system. PAPPA increases IGF bioavailability and mitogenic effectiveness in vitro through regulated cleavage of IGF-binding protein 4 (IGFBP4). To determine its function in vivo, we generated PAPPA-null mice by gene targeting. Mice homozygous for targeted disruption of the PAPPA gene were viable but 60% the size of wild-type littermates at birth. The impact of the mutation was exerted during the early embryonic period prior to organogenesis, resulting in proportional dwarfism. PAPPA, IGF2 and IGFBP4 transcripts co-localized in wild-type embryos, and expression of IGF2 and IGFBP4 mRNA was not altered in PAPPA-deficient embryos. However, IGFBP4 proteolytic activity was completely lacking in fibroblasts derived from PAPPA-deficient embryos, and IGFBP4 effectively inhibited IGF-stimulated mitogenesis in these cells. These results provide the first direct evidence that PAPPA is an essential growth regulatory factor in vivo, and suggest a novel mechanism for regulated IGF bioavailability during early fetal development.

AB - Pregnancy-associated plasma protein A (PAPPA) is a metzincin superfamily metalloproteinase in the insulin-like growth factor (IGF) system. PAPPA increases IGF bioavailability and mitogenic effectiveness in vitro through regulated cleavage of IGF-binding protein 4 (IGFBP4). To determine its function in vivo, we generated PAPPA-null mice by gene targeting. Mice homozygous for targeted disruption of the PAPPA gene were viable but 60% the size of wild-type littermates at birth. The impact of the mutation was exerted during the early embryonic period prior to organogenesis, resulting in proportional dwarfism. PAPPA, IGF2 and IGFBP4 transcripts co-localized in wild-type embryos, and expression of IGF2 and IGFBP4 mRNA was not altered in PAPPA-deficient embryos. However, IGFBP4 proteolytic activity was completely lacking in fibroblasts derived from PAPPA-deficient embryos, and IGFBP4 effectively inhibited IGF-stimulated mitogenesis in these cells. These results provide the first direct evidence that PAPPA is an essential growth regulatory factor in vivo, and suggest a novel mechanism for regulated IGF bioavailability during early fetal development.

KW - Gene targeting

KW - Insulin-like growth factor

KW - Metalloproteinase

KW - Pregnancy associated plasma protein A

UR - http://www.scopus.com/inward/record.url?scp=1642311220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642311220&partnerID=8YFLogxK

U2 - 10.1242/dev.00997

DO - 10.1242/dev.00997

M3 - Article

VL - 131

SP - 1187

EP - 1194

JO - Development (Cambridge)

JF - Development (Cambridge)

SN - 0950-1991

IS - 5

ER -